조영제 시장은 US$ 5,599.6에서 2028년까지 US$ 8,391.1백만에 이를 것으로 예상됩니다. 2022년에는 백만 달러; 2022년부터 2028년까지 CAGR 7.0%로 성장할 것으로 예상됩니다.
조영제는 초음파나 전자기 방사선이 신체를 통과하는 방식을 변경하여 표적 조직의 방사선 밀도를 향상시키는 데 사용되는 물질입니다. 이러한 물질은 직장, 경구 또는 정맥 주사로 투여할 수 있습니다. 조영제 유형의 선택은 영상의 방식과 목적에 따라 다릅니다. 만성 질환의 유병률 증가, 조영제 승인 건수 증가, 진단 영상 기법의 개발 등이 시장 성장에 기여하는 주요 요인 중 하나입니다. 그러나 조영제의 부작용은 사용을 방해합니다.
조영제 시장은 다음과 같이 분류됩니다. 유형, 영상 이동성, 적응증, 투여 경로 및 지리의 기초. 이 보고서는 시장 동향, 기술 발전, 시장 역학, 경쟁 환경 분석(선도적인 시장 참가자)과 같은 매개변수를 강조하면서 시장에 대한 통찰력과 심층 분석을 제공합니다.
전략적 통찰력
조영제 시장의 수익성이 높은 지역
시장 통찰력
< h3>만성 질환의 발생률 및 유병률 증가로 시장 성장 촉진
만성 심혈관, 호흡기, 정형외과 질환과 다양한 유형의 암으로 인해 장애와 사망이 발생하고 있습니다. 세계적인. 이러한 임상적 상태는 전반적인 삶의 질에 영향을 미칩니다. 세계보건기구(WHO)에 따르면 전 세계 인구의 약 50%가 적어도 하나의 만성 질환을 앓고 있는 것으로 추정됩니다. 질병통제예방센터(CDC)는 2019년 미국 인구 10명 중 6명이 적어도 하나의 만성 질환을 앓았다고 밝혔습니다. 심혈관 질환(CVD)은 전 세계적으로 사망의 중요한 원인입니다. 미국심장협회(American Heart Association)에 따르면 미국에서는 심부전 발병률이 증가하고 있습니다. 2019년에 미국에서는 약 874,613명이 심혈관 질환으로 사망했습니다. Single Care가 발표한 기사에 따르면, 2021년 기준 전 세계적으로 3억 5천만 명이 넘는 사람들이 관절염을 앓고 있습니다. 미국, 일본, 한국, 캐나다, 영국, 스페인, 프랑스(중국, 인도, 사우디아라비아, UAE 및 브라질) 관절염 위험이 더 큰 노인 인구의 상당한 증가를 목격하고 있습니다. 따라서 만성 질환의 유병률이 증가함에 따라 X-Ray/CT, 자기공명영상, 그리고 초음파가 전 세계 조영제 시장 성장을 주도하고 있습니다.
< h3>관리 기반 통찰력 경로
투여 경로에 따라 조영제 시장은 혈관 내, 경구 및 직장으로 분류됩니다. 혈관 내 부문은 2022년 가장 큰 시장 점유율을 차지했으며 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다. 이 부문의 시장 성장은 신체의 어느 부위에나 물질을 전달할 수 있는 능력으로 인해 조영제 주사의 광범위한 사용에 기인합니다.
영상 방식 기반 통찰력
영상 기법을 기준으로 조영제 시장은 X-Ray/CT, 자기공명영상, 초음파로 분류됩니다. X-Ray/CT 부문은 2022년에 가장 큰 시장 점유율을 차지했습니다. 그러나 초음파 부문은 2022~2028년 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.
북미는 조영제 시장의 주요 점유율을 차지하고 있으며 예측 기간 동안 유사한 추세를 보일 것으로 예상됩니다. 미국은 이 지역에서 조영제를 가장 많이 소비하는 국가입니다. 최초의 가돌리늄 기반 조영제가 미국에서 승인되었습니다. 또한, 지난 10년 동안 미국에서 4개의 추가 제제가 FDA 승인을 받았는데, 이는 미국에서 보다 효율적이고 안전하며 정확한 제제를 도입하려는 강한 경향을 나타냅니다. 더욱이 신경계 및 심혈관 질환과 같은 만성 질환 발병률의 급증은 미국의 조영제 시장 성장을 이끄는 주요 요인입니다. 모든 영상 기법 중에서 초음파 기술 분야에서 조영제에 대한 수요가 상당히 높습니다.
조영제 시장은 유형을 기준으로 분류됩니다. , 영상 양식, 적응증, 투여 경로 및 지역. 유형에 따라 시장은 요오드화 조영제, 가돌리늄 기반 조영제, 바륨 기반 조영제 및 마이크로버블 조영제로 분류됩니다. 영상 방식 측면에서 시장은 X-Ray/CT, 자기공명영상, 초음파로 구분됩니다. 적응증에 따라 시장은 심혈관 장애, 암, 위장 장애, 근골격 장애, 신경 장애 및 신장 장애. 조영제 시장은 투여 경로에 따라 혈관 내, 경구 및 직장으로 분류됩니다. 지역에 따라 시장은 북미(미국, 캐나다, 멕시코), 유럽(영국, 독일, 프랑스, 이탈리아, 스페인 및 기타 유럽), 아시아 태평양(중국, 일본, 인도, 한국)으로 분류됩니다. , 호주 및 기타 아시아 태평양 지역), 중동 및 아프리카(UAE, 사우디아라비아, 남아프리카공화국, 기타 중동 및 아프리카), 남부 및 아프리카 중앙 아메리카(브라질, 아르헨티나, 중남미 나머지 지역).
회사 프로필
- 제너럴 일렉트릭
- Bayer AG
- 브라코
- 게르베
- Lantheus Medical Imaging Inc< /span>
- nanoPET Pharma GmbH
- Unijules Life Science Ltd
- Magnus Health Management Pvt Ltd
- JB Chemical and Pharmaceuticals Ltd
- Jodan Expoim
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. General Electric
2. Bayer AG
3. Bracco
4. GUERBET
5. Lantheus Medical Imaging, Inc.
6. nanoPET Pharma GmbH
7. Unijules Life Sciences Ltd.
8. Magnus Health Management Pvt Ltd.
9. J.B.Chemicals and Pharmaceuticals Ltd.
10. Jodas Expoim
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)